NCT06707025 The Expression of CD24 "do-not-eat-me" Signal in Cholangiocarcinoma Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06690281 A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies Status WITHDRAWN Phase PHASE2
NCT06670547 Spanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde Cholangiopancreatography Status NOT_YET_RECRUITING Phase N/A
NCT06658587 A Novel Serological Risk Model for Early Non-invasive Diagnosis of Cholangiocarcinoma Status NOT_YET_RECRUITING Phase N/A
NCT06651346 Cell-Surface Plectin in the Diagnosis of Cholangiocarcinoma from ERCP-directed Biliary Samples Status NOT_YET_RECRUITING Phase N/A
NCT06648057 Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab Status RECRUITING Phase N/A
NCT06607302 Ivosidenib in Locally Advanced or Metastatic Cholangiocarcinoma With IDH1 R132 Mutation After at Least One Prior Systemic Treatment - an Observational Study Status RECRUITING Phase N/A
NCT06570174 Oral Protein Supplements for Nutritional and Quality of Life Improvement After Pancreatic Resection in Elderly Patients Status COMPLETED Phase NA
NCT06546969 Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer Status RECRUITING Phase PHASE1
NCT06541652 A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers Status RECRUITING Phase N/A
NCT06530823 Pemigatinib Combined With Durvalumab for Previously Treated Biliary Tract Carcinoma Status NOT_YET_RECRUITING Phase PHASE2
NCT06503146 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection Status RECRUITING Phase PHASE2
NCT06490198 Phase 2 Study: OBI-833/OBI-821 Maintenance for Globo H+ Advanced Biliary Tract Cancer After Gemcitabine/Cisplatin Status NOT_YET_RECRUITING Phase PHASE1
NCT06474091 Liquid Biopsy MonitORing Of CholangioCarcinOma for Treatment Response and Prognostic Outcomes (MOROCCO) Status ENROLLING_BY_INVITATION Phase N/A
NCT06441747 Phase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP) Status RECRUITING Phase PHASE2
NCT06438822 Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma Status RECRUITING Phase PHASE2
NCT06434493 Evaluation of Combined Modality Protons and Hepatic Transplantation for Hilar Cholangiocarcinoma Status NOT_YET_RECRUITING Phase NA
NCT06416397 Diagnostic Approach for Cholangiocarcinoma Using Liquid Bile Biopsy Status RECRUITING Phase N/A